Chief Executive OfficerPrior to joining IlluminOss, Mr. Jeff Bailey most recently served as Chairman and CEO of Neurovance. He brings over 30 years of leadership experience across various functional areas including supply chain, commercial, finance, R&D and business development. In Q1 of 2017 he led Neurovance’s acquisition by Otsuka. Previously, he has held positions as President and CEO of Lantheus Medical Imaging Inc., leading the company to a successful IPO. He also served as COO of Fougera Pharmaceuticals (acquired by Novartis), Chief Commercial Officer for King Pharmaceuticals (acquired by Pfizer), and held earlier executive positions at Novartis Pharmaceuticals as president of an operating unit. He was with Johnson and Johnson (including Janssen Pharmaceuticals) for 22 years. Bailey earned a business degree from Rutgers University. He also served on the board of Landauer, Inc. (NYSE – LDR) through its acquisition by Fortive in September 2017.